articleTop 1% cited
Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: Data from the CATIE schizophrenia trial sample at baseline
Schizophrenia Research · 2006 · Vol. 86(1-3) · pp. 15–22
Henry A. Nasrallah✉(University of Cincinnati)Jonathan M. Meyer(VA San Diego Healthcare System)Donald Goff(Massachusetts Mental Health Center)Joseph P. McEvoy(Duke University)Sonia M. Davis(IQVIA (United States))T. Scott Stroup(University of North Carolina at Chapel Hill)Jeffrey A. Lieberman(Columbia University)
Schizophrenia research and treatmentBipolar Disorder and TreatmentDiabetes Treatment and ManagementDyslipidemiaMedicineDiabetes mellitusSchizophrenia (object-oriented programming)Internal medicineHyperlipidemiaPopulationPsychiatryDiseaseEndocrinology
MeSH terms
Antihypertensive AgentsBlood GlucoseBlood PressureClinical Trials as TopicDiabetes MellitusFemaleHumansHypertensionMaleRisk FactorsSchizophreniaPrevalenceDyslipidemias
Funding
- National Institute of Mental Health
Citations
558
FWCI
15.83
field-weighted impact
References
59
Percentile
100%
vs. same field & year
Citations per year
Cited by
Schizophrenia, “just the facts” 4. Clinical features and conceptualization
Schizophrenia Research · 2009 · 1,010 citations
Schizophrenia, “Just the Facts”: What we know in 2008
Schizophrenia Research · 2008 · 402 citations
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
Molecular Psychiatry · 2007 · 708 citations
References
Mortality and causes of death in schizophrenia in Stockholm County, Sweden
Schizophrenia Research · 2000 · 679 citations
Prevalence and Correlates of Diabetes in National Schizophrenia Samples
Schizophrenia Bulletin · 2000 · 573 citations
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
Schizophrenia Research · 2005 · 1,134 citations
Schizophrenia and increased risks of cardiovascular disease
American Heart Journal · 2005 · 1,066 citations
The effects of antipsychotic therapy on serum lipids: a comprehensive review
Schizophrenia Research · 2004 · 409 citations
A comparison of ten-year cardiac risk estimates in schizophrenia patients from the CATIE study and matched controls
Schizophrenia Research · 2005 · 530 citations
Excess mortality of schizophrenia
The British Journal of Psychiatry · 1997 · 867 citations
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: Schizophrenia Trial Design and Protocol Development
Schizophrenia Bulletin · 2003 · 643 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.